Related Experiment Video
Updated: Aug 7, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
[The calculation of AIDS costs in Spain by simulation technics]
F Antoñanzas Villar1, F Antón Botella, C Juárez Castello
1Departamento de Economía y Empresa, Universidad de La Rioja, Logroño.
Summary
This study models the economic costs of treating HIV and AIDS in Spain. The model predicts significant healthcare expenses, highlighting the need for data-driven public health policies.
Area of Science:
- Epidemiology
- Health Economics
- Public Health Policy
Context:
- The treatment of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) presents substantial economic challenges for healthcare systems.
- Accurate cost prediction is crucial for resource allocation and policy development in Spain.
Purpose:
- To develop a quantitative model integrating clinical and epidemiological data to estimate the future economic costs of HIV and AIDS treatment in Spain.
- To predict the evolution of HIV/AIDS and associated healthcare expenditures for the Spanish health care system in 1995.
Summary:
- A probabilistic model was created, classifying AIDS patients into early, intermediate, and advanced stages, with associated treatment costs.
- The model, programmed on a spreadsheet, allows for simulating disease progression and its financial impact.
- In 1995, an estimated 22,000 patients with HIV/AIDS required significant hospital resources, projecting costs around 113,000 million pesetas.
Impact:
- The model highlights the substantial healthcare costs associated with HIV and AIDS treatment.
- It underscores the necessity for robust clinical, epidemiological, and economic data to inform effective public health policies and resource management.
- Simulation capabilities enable scenario planning for future healthcare needs and budget allocation.
More Related Videos
Related Concept Videos
Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Statistical Software for Data Analysis and Clinical Trials
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

